2nd Quarter - Report

THE NICKLES GROUP, LLC for MERCK & CO. INC.

Period 2nd Quarter 2025 Filed Jul 17, 2025 Signed by Greg D'Angelo

Official filing
Firm
THE NICKLES GROUP, LLC
Client
MERCK & CO. INC.
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to drug pricing and implementation of the Inflation Reduction Act. H.R. 946/S. 1862, ORPHAN Cures Act. H.R. 1492, the Ensuring Pathways to Innovative Cures Act. H.R.1, One Big Beautiful Bill Act, as it relates to drug pricing and pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.

LobbyistCovered position, as disclosed
BRETT BAKER —
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); White House Office; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1492 (119th), S. 1862 (119th), H.R. 946 (119th), H.R. 1 (119th)

Taxation/Internal Revenue Code TAX

H.R. 1, One Big Beautiful Bill Act, as it relates to corporate taxes.

LobbyistCovered position, as disclosed
GREG D'ANGELO —
RACHEL JONES HENSLER —

Contacted: HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; White House Office

Bills named: H.R. 1 (119th)

Trade (domestic/foreign) TRD

Issues related to tariffs.

LobbyistCovered position, as disclosed
GREG D'ANGELO —
RACHEL JONES HENSLER —

Contacted: White House Office; SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to pharmacy benefit management reforms. Issues related to vaccine policy. Issues related to supply chain and domestic manufacturing capacity.

LobbyistCovered position, as disclosed
BRETT BAKER —
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; White House Office; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.